Saturday, November 8, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Expedia Stock: Soars to Record High on Stellar Earnings

Robert Sasse by Robert Sasse
August 9, 2025
in Stocks
0
Expedia Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Expedia’s shares surged 13.5% to a 52-week high of $212.06 on Friday, capping a 59.75% annual gain, fueled by stronger-than-expected Q2 results. The travel giant reported earnings of $4.24 per share, surpassing forecasts of $3.96, while revenue hit $3.79 billion against estimates of $3.7 billion. Key growth drivers included a 17% jump in B2B bookings and a 19% rise in advertising revenue, underscoring its robust international presence. Adjusted EBITDA margins expanded by 190 basis points to 24%, reflecting improved profitability.

Analysts Rally Behind Upgraded Targets

Wall Street responded with bullish price-target hikes, including raises to $218 (DA Davidson) and $240 (BofA). Efficiency gains—from job cuts and AI adoption—slashed overhead costs to 16.8% of revenue. While U.S. consumer demand remained subdued, international leisure bookings grew 13%, and CEO Ariane Gorin noted a recent uptick in American travel sentiment. Expedia raised its full-year booking growth forecast to 3–5%, with margins expected to improve by another 100 basis points. The stock’s pre-market spike to $216 signals sustained investor confidence.

Ad

Expedia Stock: Buy or Sell?! New Expedia Analysis from November 8 delivers the answer:

The latest Expedia figures speak for themselves: Urgent action needed for Expedia investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 8.

Expedia: Buy or sell? Read more here...

Tags: Expedia
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Münchener Rück Stock

Münchener Rück Stock: Record Profit Masked by Market Jitters

Gilead Sciences Stock

Gilead Sciences Stock: HIV Success Fuels Analyst Optimism

The Trade Desk Stock

The Trade Desk Stock: Plunges 32% on Downgrade, Growth Fears

Recommended

Myers Industries Stock Surges 13 After Strong Q4 Results and FY24 Guidance

2 years ago
Wolfspeed Stock

Semiconductor Stock Faces Turbulence Amid Financial Restructuring

2 months ago
AT&T Stock

AT&T’s Strategic Pivot: Balancing Ambitious Investment Against Mounting Debt

2 months ago
Accuray Stock

Accuray Navigates Market Headwinds with Cautious Optimism

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Jasper Therapeutics Faces Legal Storm Amid Clinical Trial Setbacks

Aqua Metals Stock: Deep-Sea Venture and Earnings Report Set Stage for Volatility

Leslie’s Stock Navigates Choppy Waters Amidst Glimmers of Hope

Beyond Meat Shares Swing Wildly Amid Financial Turmoil and Operational Updates

Tech Stocks Face Mounting Pressure as Key Support Level Tested

Harvard Bioscience Stock: A Contradiction of Weak Earnings and Financial Improvement

Trending

Quantum Computing Stock
AI & Quantum Computing

Quantum Computing Stock Plummets Amidst Financial Turmoil

by Dieter Jaworski
November 8, 2025
0

Quantum Computing shares are experiencing a dramatic collapse, with the stock's valuation plunging nearly 25 percent within...

Apyx Medical Stock

Apyx Medical Shares Surge on Strong Quarterly Results

November 8, 2025
CorVel Stock

CorVel’s AI Strategy Faces Market Valuation Test

November 8, 2025
Jasper Therapeutics Stock

Jasper Therapeutics Faces Legal Storm Amid Clinical Trial Setbacks

November 8, 2025
Aqua Metals Stock

Aqua Metals Stock: Deep-Sea Venture and Earnings Report Set Stage for Volatility

November 8, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Quantum Computing Stock Plummets Amidst Financial Turmoil
  • Apyx Medical Shares Surge on Strong Quarterly Results
  • CorVel’s AI Strategy Faces Market Valuation Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com